Company Profile

A) AS ASIA’S LARGEST CONTRACT MANUFACTURING COMPANY, AKUMS MANUFACTURES MORE THAN 12.5% OF COUNTRY’S DOMESTIC CONSUMPTION OF MEDICINES. B) AKUMS MANUFACTURES NEARLY 4000 + DIFFERENT FORMULATIONS AND 14500 BRANDS IN ALMOST ALL THERAPEUTIC SEGMENTS. C) AKUMS HAS 11 STATE-OF-ART PHARMA FORMULATIONS PLANTS, HARIDWAR, GUWAHATI, KOTDWAR & BADDI. D) AKUMS ALSO HAS 3 API PLANTS FOR BACKWARD INTEGRATION AND FOR EXPORTS OF API’S AND INTERMEDIATES. THE MANUFACTURING PLANTS ARE LOCATED AT PUNJAB AND HARYANA. E) AKUMS HAS STRONG 1100+ DOMESTIC CLIENT BASE AND EXPORTING PRODUCTS TO 53 COUNTRIES OF SOUTH EAST ASIA, AFRICA, LATAM MARKET. ALSO DEVELOPING PRODUCTS FOR WHO – GENEVA, CHINA & JAPAN MARKET. F) IN SEP 2022, AKUMS 2 PLANTS GOT EU - GMP APPROVAL. G) MORE THAN 890+ “NEW DRUG APPROVALS” HAVE BEEN RECEIVED FROM D.C.G.I * H) 635+ PRODUCT APPROVALS HAVE BEEN RECEIVED FROM FSSAI * I) FILED 79 APPLICATIONS FOR PATENT – 4 PATENTS GRANTED * J) 5 R&D FACILITIES APPROVED BY DSIR; NABL APPROVED LABORAT